(1-4). The enzyme is an ␣ 2  2 complex, consisting of two ␣-subunits bound to a central  2 -dimer. Each ␣-subunit independently catalyzes the reversible aldol cleavage of indole-3-glycerol phosphate to indole and D-glyceraldehyde 3-phosphate (␣-reaction, Reaction 1). The -subunit catalyzes the conversion of indole and Lserine to L-Trp, with PLP as the cofactor (-reaction, Reaction 2). The overall reaction is the combination of the ␣-reaction and the -reaction (␣-reaction, Reaction 3). Indole is not observed as a free intermediate in the ␣-reaction (5-9), suggesting that indole is not released from the ␣-subunit of Trp synthase into solution during turnover; hence, Reaction 3 is the physiological reaction of Trp synthase. X-ray crystallographic investigations of Trp synthase from Salmonella typhimurium have revealed a 25-30-Å long interenzyme tunnel linking the ␣-and -active sites, through which it has been proposed that indole travels to the -active site directly from the ␣-active site after formation (10 -14). Moreover, intermediate complexes of the ␣-and -reactions reciprocally regulate catalysis at the other site in an allosteric manner (11,(15)(16)(17). These allosteric interactions coordinate the forward progress of the ␣-reaction.In the absence of substrate, PLP is bound to Lys87 in the form of the internal aldimine (E A ) (Scheme 1) (18). The reaction of L-Ser at the -site, promoted by the presence of indole-3-glycerol phosphate bound at the ␣-active site, forms an external aldimine (E EA-Ser ), which is converted to an ␣-aminoacrylate Schiff's base (E AA ) with elimination of water, by the action of Lys87 as a general base (19). In return, formation of the ␣-aminoacrylate Schiff's base with PLP at the -site activates the ␣-reaction (20). D-Glyceraldehyde 3-phosphate bound to the ␣-site keeps the ␣-site closed, blocking the release of indole into solution and facilitating transfer of indole from the ␣-and -active sites through the interenzyme tunnel. Nucleophilic addition of indole to the ␣-aminoacrylate intermediate at the -site then affords the quinonoid intermediate of L-Trp (E Q ). Glu109 activates the addition of indole, a weak nucleophile, probably by acting as a general base or H-bond acceptor to the N-H of the reacting indole (21). At this point, Lys87 acts as a general acid, providing the proton for the conversion of E Q to the L-Trp external aldimine (E EA-Trp ) (19). Release of D-glyceraldehyde 3-phosphate from the ␣-site results in an open conformation, which then allows release of the L-Trp product from the -active site. Nucleophilic attack of Lys87 on E EA-Trp
BACKGROUND: Pharmaceutical companies continue to evaluate β-amino acids and β-lactams in a range of drug candidates. The development of a highly efficient and selective bioresolution of cyclic β-lactam substrates could yield enantiopure lactams and β-amino acids with medicinal potential. The aim of this work was to discover and develop a biocatalyst capable of selectively hydrolysing β-lactam substrates.
Nitration of Nα,N1-bis(trifluoroacetyl)-L-tryptophan methyl ester with HNO3 in acetic anhydride at 0° C provides Nα-trifluoroacetyl-2-nitro-L-tryptophan methyl ester in 67% yield, whereas nitration in trifluoroacetic acid at 0° C gives Nα-trifluoroacetyl-6-nitro-L-tryptophan methyl ester in 69% yield.
Methods for the regioselective nitration of N α ,N 1 -bis(trifluoroacetyl)-L-tryptophan methyl ester (I) in the 2-or 6-position are studied. -(OSBORNE, A. S.; SOM, P.; METCALF, J. L.; PHILLIPS*, R. S.; Bioorg. Med. Chem. Lett. 18 (2008) 21, 5750-5752; Dep. Chem., Univ. Ga., Athens, GA 30602, USA; Eng.) -M. Bohle 10-188
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.